De Apotheek SA
De Apotheek reported total assets of €1.18m at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jun 2026).
The score of De Apotheek shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +46 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
De Apotheek's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jun 2026
- Year ended 31 Dec 2024filed on 20 May 2025
- Year ended 31 Dec 2023filed on 04 Jun 2024
- Year ended 31 Dec 2022filed on 23 May 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
De Apotheek's financial analysis
- Solvency10.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of De Apotheek
De Apotheek's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0426.472.079
- VAT number
- BE0426472079
- Peppol
- Registered · 0208:0426472079 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 08 Nov 1984
- Registered office
- 3530 Houthalen-Helchteren
- Latest accounts
- 2025 · filed on 16 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
De Apotheek (SA) has been based in Houthalen-Helchteren since 1984, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 13,363 € and equity of 125,537 €; its revenue is not published. Its solvency stands at 10.6%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to De Apotheek
Companies in the same business, of comparable size and area, outside its group.
- Medigrex Retail sale of pharmaceutical products Wuustwezel · balance sheet €1.18m
- Pharmacie Andromede Retail sale of pharmaceutical products Frameries · balance sheet €1.18m
- MPL Pharma Retail sale of pharmaceutical products Ciney · balance sheet €1.05m
- Brugafar Retail sale of pharmaceutical products Nieuwpoort · balance sheet €1.18m
- Apotheke Schunck Retail sale of pharmaceutical products Eupen · balance sheet €1.18m
- Pharmaphie SDW Retail sale of pharmaceutical products Ghent · balance sheet €1.19m
- Zellik Pharma Retail sale of pharmaceutical products Asse · balance sheet €1.25m
- Pharmabrussels Flagey Retail sale of pharmaceutical products Ixelles · balance sheet €1.20m
Frequently asked questions about De Apotheek
What is the revenue of De Apotheek?
De Apotheek files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of De Apotheek?
In Belgium, the VAT number is the company number prefixed with BE: BE0426472079 for De Apotheek, if the company is VAT-registered. Its company number (CBE) is 0426.472.079.
Where is the registered office of De Apotheek?
According to the CBE register, the registered office of De Apotheek is in 3530 Houthalen-Helchteren.
What is the equity of De Apotheek?
At the close of the 2025 financial year, the equity of De Apotheek amounts to 125,537 €, a solvency of 10.6% of total assets.
Who manages De Apotheek?
The register lists 4 active mandates at De Apotheek. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of De Apotheek
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →